This topic contains a solution. Click here to go to the answer

Author Question: Which of the following is not required to be evaluated for infants and toddlers according to federal ... (Read 214 times)

TVarnum

  • Hero Member
  • *****
  • Posts: 548
Which of the following is not required to be evaluated for infants and toddlers according to federal regulations?
 
  A. Family interaction development
  B. Physical development
  C. Cognitive development
  D. Communication development

Question 2

At a minimum, which of the following indicates how often IDEA mandates the plans for infants and toddlers be evaluated?
 
  A. 3 months
  B. 4 months
  C. 6 months
  D. 12 months



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

kingdude89

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

A.
Explanation: Family interaction development is not required to be evaluated for infants and toddlers under federal regulations.

Answer to Question 2

D.
Explanation: Every 12 months IDEA requires that a child on an IFSP be reevaluated.




TVarnum

  • Member
  • Posts: 548
Reply 2 on: Jun 20, 2018
Gracias!


mcabuhat

  • Member
  • Posts: 344
Reply 3 on: Yesterday
Wow, this really help

 

Did you know?

Parkinson's disease is both chronic and progressive. This means that it persists over a long period of time and that its symptoms grow worse over time.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

Asthma attacks and symptoms usually get started by specific triggers (such as viruses, allergies, gases, and air particles). You should talk to your doctor about these triggers and find ways to avoid or get rid of them.

Did you know?

Most women experience menopause in their 50s. However, in 1994, an Italian woman gave birth to a baby boy when she was 61 years old.

Did you know?

For high blood pressure (hypertension), a new class of drug, called a vasopeptidase blocker (inhibitor), has been developed. It decreases blood pressure by simultaneously dilating the peripheral arteries and increasing the body's loss of salt.

For a complete list of videos, visit our video library